Introduction
The outstanding properties of nanometer-scale materials, in particular their small sizes, are very attractive for biomedical applications including diagnostics and therapy of various diseases.
1,2 Special attention is paid to particles with magnetic properties, which represent multifunctional materials used for magnetic resonance imaging (MRI) contrast agents, 3 drug and gene delivery, [4] [5] [6] hyperthermia to treat cancer, 7 and separation of cells and specic molecules from body liquids. 8 Magnetic nanomaterials are typically based on ferromagnetic elements such as iron, cobalt, nickel, or their oxides and alloys. The physical and chemical properties of magnetic nanoparticles are strongly associated with their composition, morphology, size, and distribution. Requisite characteristics of the particles can be tailored by selection of a proper preparation method, e.g., co-precipitation, 9 spray pyrolysis, 10 hydrothermal, 11 sol-gel, 12 or thermal decomposition. However, magnetic nanoparticles for theranostic applications must meet additional criteria. These involve low toxicity, biocompatibility, proper in vitro and in vivo interactions with living cells, and convenient dosage. 13 Among the magnetic nanoparticles, a dominant role is played by iron oxides, mainly maghemite (gFe 2 O 3 ) and magnetite (Fe 3 O 4 ), which are known to be nontoxic (biocompatible) and have been approved by the Food and Drug Administration as a contrast agent for MRI.
14,15
Monodisperse magnetic nanoparticles with tunable properties are generally prepared by thermal decomposition of metal organic precursors; however, such particles are hydrophobic. Since bioapplications using nanomaterials require particle dispersibility in aqueous media, silica is oen used as a coating material. 16 Silica is biocompatible, optically transparent, chemically inert, thermally stable, and has a large surface area available for the loading of required drugs. 17 In addition, silica can be easily modied with various reactive groups by the addition of appropriate silane derivatives during synthesis. Due to a large specic surface area and a negative charge, silicacoated magnetic nanoparticles have a tendency to adsorb proteins from blood plasma, which leads to undesirable particle aggregation. 18 As a result, the particles are rapidly shuttled out of blood circulation and internalized by macrophages and endothelial cells of the reticuloendothelial system, in particular to the liver and spleen. 19 To obtain not only a stable colloid without particle aggregation, but also prevent undesirable protein adsorption and prolong half-life time in the blood stream, the nanoparticle surface has to be further modied. The surface coating determines the interaction of the particles with the membranes of living cells. This controls the particle uptake by different cell types and inuences biocompatibility, as well as the distribution of the nanoparticles in the tissues of living organisms. Recently, many materials, such as dopamine, 20 ascorbic acid, 21 peptides, 22 mono- 23 and polysaccharides, 24 and poly(ethylene glycol) (PEG), 25 have been proposed for particle coating by physical adsorption or chemical binding. PEG in particular is considered to be a very promising material, that protects the nanoparticles from the immune system, promotes a longer circulation time, and inhibits removal by the reticuloendothelial system. Moreover, PEG is inexpensive and FDAapproved for a wide range of bioapplications. 25 The aim of this work is to design, prepare, and characterize monodisperse silica-coated magnetite nanoparticles (Fe 3 2 -PEG particles were determined using a murine neural stem cell model, while their potential for biomedical use was evaluated by means of stem cell labeling and ex vivo MRI visualization of particles in the mouse brain.
Experimental

Chemicals and materials
Octadec-1-ene (OD), icosane (IS), tetramethyl orthosilicate (TMOS), (3-aminopropyl)triethoxysilane (APTES), Igepal CO-520 [polyoxyethylene (5) nonylphenylether], succinic anhydride, N,Ndiisopropylethylamine, and Dulbecco's modied Eagle's medium (DMEM) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Oleic acid (OA), ammonium uoride, acetone, dichloromethane (distilled), and ethanol were obtained from Lachema (Brno, Czech Republic). Methoxy poly(ethylene glycol) succinimidyl active ester (PEG-NHS; M w ¼ 2000) was purchased from Rapp Polymere (Tuebingen, Germany). Cellulose dialysis membranes (14 kDa) were obtained from Spectrum Europe (Breda, Netherlands). Fe(III) oleate was prepared according to an earlier report 26 Ultrapure Q-water ultraltered on a Milli-Q Gradient A10 system (Millipore; Molsheim, France) was used in biological experiments.
Molecular Probes LIVE/DEAD™ viability/cytotoxicity and MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) kits were from Invitrogen (Fisher Scientic; Hampton, NH, USA). DMEM/F-12, GlutaMAX, B27 factor, penicillin, streptomycin, epidermal growth factor (EGF), and broblast growth factor (FGF) were obtained from Life Technologies (Carlsbad, CA, USA). All other chemicals were purchased from Sigma-Aldrich.
Neural stem cell culture. Murine neural stem cells (mNSCs) were isolated from embryos of pregnant female mice (inbred strain C57Bl/6NCrl) as previously described. 27 All animal procedures were approved by the Internal Review Board of the Ethical Committee of the School of Medicine, University of Zagreb and were in accordance with the Ethical Codex of Croatian Society for Laboratory Animal Science and the EU Directive 2010/63/EU on the protection of animals used for scientic purposes.
The telencephalic walls of embryos at gestation day 14.5 were microdissected and dissociated using StemPro Accutase (Life Technologies). Cells were maintained at 37 C in a humidied 5% CO 2 To a dispersion of Fe 3 O 4 nanoparticles (30 mg) in hexane (10 mL), Igepal CO-520 (0.5 mL) and 25% NH 4 OH (0.08 mL) were added, and the mixture was sonicated (Sonopuls sonicator; Bandelin; Berlin, Germany) at RT for 30 min. Aer addition of TMOS (0.04 mL), the reaction mixture was stirred (600 rpm) at RT for 48 h. To produce Fe 3 O 4 &SiO 2 -NH 2 nanoparticles, APTES (0.02 mL) was added, and the reaction was continued at RT for an additional 24 h. Fe 3 O 4 &SiO 2 and Fe 3 O 4 &SiO 2 -NH 2 nanoparticles were precipitated in acetone (10 mL), separated by centrifugation (4000 rpm), and washed with ethanol and water ve times each to remove residual surfactant. Finally, the nanoparticles were dialyzed against water at RT for 48 h using Spectra/Por® cellulose membrane (14 kDa; Spectrum; Rancho Dominguez, CA, USA).
PEGylation of Fe 3 O 4 &SiO 2 -NH 2 nanoparticles
To PEGylate the Fe 3 O 4 &SiO 2 -NH 2 particles (30 mg), they were dispersed in dichloromethane (10 mL), PEG-NHS (40 mg) was added, and the mixture was stirred (200 rpm) at RT for 12 h. Residual amino groups on the particles were reacted with succinic anhydride (10 mg) and N,N-diisopropylethylamine (25 mL)
at RT for 1 h with stirring (200 rpm). The resulting Fe 3 O 4 &SiO 2 -PEG particles were precipitated by acetone (5 mL), dispersed in ethanol, purged with Ar for 10 min to remove dichloromethane, separated by centrifugation (4000 rpm), dispersed in water, and nally dialyzed against water at RT for 24 h to remove unreacted PEG.
Physico-chemical characterization of the nanoparticles
Electron microscopy. The morphology (shape, diameter, and size distribution), crystal structure, and composition of the magnetic particles were investigated using a Tecnai G2 Spirit Twin 12 transmission electron microscope (TEM; FEI; Brno, Czech Republic) equipped with an energy dispersive spectrometer (EDX; Mahwah, NJ, USA). The weight-averaged diameter (D w ), number-averaged diameter (D n ), and uniformity (polydispersity index PDI ¼ D w /D n ) were calculated from at least 500 individual particles using Atlas soware (Tescan; Brno, Czech Republic). D n and D w were calculated as follows:
where n i and D i are the number and diameter of the nanoparticle, respectively. The crystal structure of the nanoparticles was veried by selected area electron diffraction (SAED (SSC) . Internalization of the nanoparticles in mNSCs was evaluated using a Molecular Probes LIVE/DEAD™ viability/ cytotoxicity kit. Cells were seeded in 6-well plates and incubated with increasing particle concentrations (2, 20 , and 200 mg L
À1
) for 24 h. The highest nanoparticle dose was run rst to set the range for the maximum SSC signal. Non-treated cells were used as a negative control. Dissociated cells were incubated with 0.1 mM calcein acetoxymethyl ester (CAM) and 3 mM ethidium homodimer-1 (EthD), both supplied in the kit, at RT for 15 min in the dark. Each experiment was repeated three times. CAM and EthD were measured using log ampliers. The percentage of particle-labeled cells was determined by measuring the increase in the SSC signal. The SSC intensity was proportional to the intracellular density and granularity. 33 The percentage of positive cells (compared to the control) was determined with FCS Express 5 ow cytometry soware using the Overton cumulative histogram subtraction method. 6 and 20% HCl (1 : 1 mol mol À1 ) for 20 min. Cells were counterstained with 0.1% nuclear fast red for 1 min, mounted with HistoMount (Invitrogen), and covered by coverslips. Aer drying, the cells were viewed using an ECLIPSE E200 light microscope (Nikon Instruments; Tokyo, Japan) under bright eld. Determination of particle uptake by inductively coupled plasma mass spectrometry (ICP-MS). The cells were seeded in 6-well tissue culture plates, exposed to Fe 3 O 4 &SiO 2 or Fe 3 O 4 &SiO 2 -PEG nanoparticles for 24 h, washed several times with PBS, and suspended in 10 mM phosphate buffer (pH 7.5). The harvested cells were transferred in closed vessels and digested with an UltraCLAVE IV Milestone digestion device (MikrowellenLaborsysteme; Leutkirch, Germany) using the US EPA 3052 method. The particle uptake by the mNSCs was quantied by measuring the total Fe contents in the digested cells by an Agilent Technologies 7500cx ICP-MS (Waldbronn, Germany).
TEM of particle-labelled mNSCs. Aer labeling, the cells were detached from the surface by a 10 min treatment with StemPro Accutase reagent, washed once with DMEM/F-12 medium, separated by centrifugation, xed overnight with 2% glutaraldehyde in 0.1 M phosphate buffer, post-xed in 1% osmium tetroxide, and contrasted in 2% uranyl acetate. The cells were dehydrated in acetone and embedded in Durcupan resin. Ultrathin sections were then cut on an RMC Power Tome XL ultramicrotome (Boeckeler Instruments; Tucson, AZ, USA) and were contrasted with uranyl acetate and lead citrate and visualized using a 902A TEM microscope (Zeiss; Oberkochen, Germany).
Biocompatibility and biosafety of Fe 3 O 4 &SiO 2 and Fe 3 O 4 &SiO 2 -PEG nanoparticles
Cell viability assay. Cell viability was determined by measuring the cellular metabolic activity using the MTT assay based on the reduction of the yellow tetrazolium salt to purple formazan crystals. mNSCs were plated on a 96-well plate in DMEM/F-12 medium with GlutaMAX for 24 h. Fe 3 O 4 &SiO 2 and Fe 3 O 4 &SiO 2 -PEG nanoparticles were added to quintuplicate wells at concentrations ranging over 0-200 mg L À1 and incubated for another 24 h. Non-treated cells were used as negative controls, while mNSCs treated with dimethyl sulfoxide (DMSO) were used as positive controls. Aer the treatment, the medium from each well was removed by aspiration, the cells were carefully washed three times with 200 mL PBS per well to remove all particles that may interfere with the MTT assay, 35 MTT solution (50 mL; 1000 mg L À1 ) was added to each well, and the cells were incubated at 37 C for 4 h. The MTT solution from each well was removed by aspiration, which was followed by the addition of DMSO (50 mL) to dissolve formazan crystals. The optical density was measured in each well using a Victor™ multilabel plate reader (Perkin Elmer; Waltham, MA, USA) at 595 nm. In addition, control plates with the same particle concentrations were prepared, and the background absorbance of particles was subtracted on the plate reader to avoid false positive results that may lead to an underestimation of particle toxicity. Reactive oxygen species (ROS) production. Reactive oxygen species (ROS) production in mNSCs treated with the particles was determined using 2 0 ,7 0 -dichlorodihydrouorescein diacetate (DCFH-DA), which penetrates cell membranes freely and is hydrolyzed by cellular esterases to form 2 0 ,7 0 -dichlorodihydrouorescein, which is oxidized to the uorescent 2 0 ,7 0 -dichlorouorescein (DCF) in the presence of hydroxyl radicals.
36 Cells were exposed to increasing concentrations of Fe 3 O 4 &SiO 2 or Fe 3 O 4 &SiO 2 -PEG nanoparticles (20, 100, and 100 mg L À1 ) at 37 C for 4 h. Non-treated cells were used as negative controls, while cells treated with 100 mM H 2 O 2 were positive controls. Aer treatment, the cells were washed three times with PBS (to avoid interference with the particles), which was followed by staining with 20 mM DCFH-DA at 37 C for 30 min. Cells were then washed with PBS twice and analyzed using a Victor™ multilabel plate reader at excitation and emission wavelengths of 485 and 535 nm, respectively. The data were expressed as percentage of uorescence compared to the relevant negative controls.
Quantication of intracellular glutathione (GSH).
The effect of treatment with increasing concentrations of Fe 3 O 4 &SiO 2 or Fe 3 O 4 &SiO 2 -PEG nanoparticles on the cellular level of intracellular GSH was estimated using a monochlorobimane (MBCl) probe, which reacts specically with GSH to form a uorescent adduct. 37 Aer treatment with the particles at 37 C for 4 h, the mNSCs were washed three times with PBS, which was followed by incubation with 50 mM MBCl at 37 C for 20 min. 
-PEG nanoparticles in mouse brain
Magnetic resonance imaging (MRI) was performed on a 7 T BioSpec 70/20 USR system (Bruker Biospin; Ettlingen, Germany) with Paravision 6.0.1. soware in a conguration using an 86 mm MT0381 transmit volume coil and a 2-element MT0042 mouse brain surface receiver coil. The samples were placed in a suitable plastic tube, which was taped to the receiver coil to lay the region of interest in the center of the eld of view (FOV). MRI relaxometry on phantoms. The phantoms consisted of Fe 3 O 4 &SiO 2 and Fe 3 O 4 &SiO 2 -PEG nanoparticles suspended in a host medium (20 vol% glycerol) and sealed in a 0.2 mL at-top tube. Maps of T 1 , T 2 , and T * 2 relaxation times were measured for each particle type at three different concentrations (10, 40 , and 100 mg L À1 ) and host medium. T 1 , T 2 , and T * 2 were compared to the results measured on native host media in the absence of the particles. The geometric parameters for all mapping sequences were identical. Two 1 mm thick slices in the FOV center, perpendicular to the phantom tube, were acquired with inplane isotropic resolution of 133 mm and slice spacing of 0.3 mm. Prior to the main scans, a localizer scan was run, followed by additional local shimming using the MAPSHIM algorithm. This was done to ensure eld homogeneity comparable to typical in vivo levels, which increases the relevance of measured T * 2 values. The sequence-specic parameters used are listed in Table S1 of ESI. † Aer acquisition, relaxation maps were calculated using Paravision's built-in post-processing tools (FitInISA macro). Circular regions of interest covering roughly one half of the tube cross-section were placed centrally over each map to avoid artifacts due to abrupt susceptibility changes between the phantom and the plastic tube. One or more shimming iterations were done, until the calculated half-power bandwidth (HPBW) of the proton frequency line was comparable to typical values obtained when applying the MAPSHIM algorithm in vivo on a mouse brain.
Ex vivo MRI visibility validation of nanoparticles in mouse brain. Fe 3 O 4 &SiO 2 and Fe 3 O 4 &SiO 2 -PEG nanoparticles were stereotaxically injected into four isolated adult mouse brains. Mice (three months-old, weighing 25-30 g) were transcardially perfused and the brains were isolated and kept in 4% (v/v) paraformaldehyde for 24 h prior to the injection. The nanoparticle dispersion was injected in the le side of the brain, while the control solution containing only host medium (20 vol% glycerol) was injected in the right side of the brain. The procedure was performed using a 900LS KOPF stereotaxic apparatus (Tujunga, CA, USA) and a 5 mL Hamilton syringe needle (Fig. S1a in ESI †) . The injections were applied in the front part of the cerebrum at approximate stereotaxic coordinates of ML AE2.0, DV À2.0 and AP À0.2 according to the stereotaxic atlas.
39 Before injecting, the needle was slightly retracted to create a small pocket for the injected liquid and to prevent spillage. The brain was then placed in a 1.8 mL freezer tube lled with Fomblin (Solvay; Brussels, Belgium) and held in place with a custom cut piece of thin plastic inserted below (Fig. S1b in ESI †) . The tube was taped to the receiver coil with the brain top facing upwards for optimal signal-to-noise performance.
Ex vivo MRI visualization. For ex vivo validation of MRI visibility of the particles in mouse brain, two high-resolution scans based on standard imaging sequences were performed: spin echo-based T 2 -and gradient echo-based T * 2 -weighted sequences using sequence-specic parameters (Table S2 in ESI †). Twelve axial slices covering the whole length of the cerebrum were set. The slice thickness was reduced to 0.5 mm, and an in-plane resolution of 80 Â 80 mm was chosen for the scans. The reduced voxel size compared to the phantom measurement (>5Â smaller volume) and the lower inherent contrast of xed tissue compared to the live organ was compensated by an increased number of averaging repetitions. No additional post-processing was done on the acquired images.
Results and discussion
Magnetite nanoparticles
Superparamagnetic Fe 3 O 4 particles were obtained by OAstabilized thermal decomposition of Fe(III) oleate. A large advantage of this technique is that it provides monodisperse particles, the size of which can be controlled in the 6-20 nm range by changing the reaction temperature and the concentration of the OA stabilizer. The tunable particle size and uniformity, as well as the reproducibility of the synthesis, are of critical importance for prospective bioapplications. The reaction temperature was controlled by selecting high-boiling solvents, such as OD and IS. As OD has a lower boiling temperature than IS, the reaction in OD produced the smaller particles No. I and II (6 and 10 nm; Fig. 1a and d, respectively) compared to the particles no. III prepared in IS (20 nm; Fig. 1g ), which was demonstrated by TEM. While the 10 nm Fe 3 O 4 particles were formed at a lower OA concentration (0.3 mmol mL À1 ), the 6 nm ones were synthesized in the presence of higher OA concentration (0.38 mmol mL À1 ). This is because an increased amount of stabilizer (OA) always produces smaller entities because it stabilizes more particles.
26,40
The morphology, coating, elemental composition, and crystal structure of the particles were veried by TEM analysis including bright eld imaging (TEM/BF), energy-dispersive Xrays analysis (TEM/EDX), and selected area electron diffraction (TEM/SAED). The TEM analysis was supplemented by FTIR measurements. The TEM/BF micrographs (Fig. 1a, d and g ) show the nanoparticle sizes as a function of experimental conditions; the SiO 2 -coating on the nanoparticle surface is seen in Fig. 2 .
TEM/SAED diffraction patterns conrmed that the nanoparticles were the magnetic form of iron oxide, i.e., magnetite (Fe 3 O 4 ) . Fig. 1a, d and g shows the TEM/BF micrographs of nanoparticles with various sizes; the medium column displays the corresponding two-dimensional experimental TEM/SAED diffraction patterns (Fig. 1b, e and h) , and the right column compares the one-dimensional, radially averaged SAED diffractograms with theoretically calculated XRD diffractograms of magnetite (Fig. 1c, f and i) . The SAED diffraction positions were in excellent agreement with the calculated XRD positions, while the SAED diffraction intensities of several reections (440 and 400) were slightly different from the calculated XRD intensities (Fig. 1c, f and i) . This difference could be attributed to the preferred orientation of the faceted Fe 3 O 4 nanocrystals lying on the electron-transparent carbon lm. Diffractions that were stronger in SAED than in XRD were of the (hk0) type, i.e., their last diffraction index was zero. This indicated that the orientation of a signicant quantity of the nanocrystals could be characterized by zone axis [001] , and the strong diffractions of the SAED pattern came from the zonal planes obeying the Weiss Zone Law (WZL). The general formula of WLS reads: hu + kv + lw ¼ 0, where (h,k,l) are the diffraction indices and (u,v,w) are the indices of the zone axis. In our specic case with zone axis [uvw] ¼ [001], the WZL was reduced to the simple form (l ¼ 0), and as a result the strongest SAED diffractions were (hk0) as discussed above and shown in Fig. 1 . For the 6 and 10 nm nanocrystals (Fig. 1a and d) , the diffraction (220) was not very strong despite obeying the WZL. This was due to the small nanocrystals (Fig. 1b and e) exhibiting less intensive diffractions than the large ones (Fig. 1h) . As a result, the (220) diffraction was partially lost in the intensity of the neighboring primary beam. More details about zone axis, WZL and SAED interpretation can be found elsewhere. 41 Here, we simply conclude that the agreement between the experimental SAED and calculated XRD patterns demonstrated that all prepared iron oxide nanoparticles had the Fe 3 O 4 crystal structure.
The diameter of the magnetic nanoparticles in hexane was additionally measured by DLS. The hydrodynamic diameter (D h ) and polydispersity (PD) of No. I, II, and III nanoparticles reached 10, 31, and 41 nm and 0.12, 0.15, and 0.19, respectively, conrming a narrow particle size distribution without any aggregation. The difference between D h values and diameters calculated from TEM micrographs (Table 1) comes from the fact that direct measurement on TEM yields number-averaged diameters of dried particles (D n ), while DLS yields intensityaveraged diameters of hydrated particles (D h ), which overestimates bigger particles and thus is sensitive to even a small amount of aggregates. Moreover, magnetic nanoparticles prepared by thermal decomposition in organic media adsorbed OA stabilizer on their surfaces, which also contributes to increased D h ; however, since the OA molecules have low atomic numbers in comparison with the iron oxide, they are not visible in the TEM micrographs. It should also be noted that Fe 3 O 4 particles with D n < 20 nm exhibited superparamagnetic behavior. 42 That means that in the absence of an external magnetic eld, the particles are dispersed in a solvent forming a colloid; however, they can be attracted by a magnet and magnetically manipulated. Moreover, such a small particle size is convenient for future applications as it avoids particle clearance by the liver and spleen. The magnetic properties of Fe 3 O 4 nanoparticles prepared by thermal decomposition of Fe(III) oleate were described in our earlier publication.
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The structure of the Fe 3 O 4 nanoparticles was analyzed by ATR FTIR spectroscopy (Fig. 3b) . Characteristic bands of asymmetric and symmetric CH 2 stretching vibrations of OA were observed at 2920 and 2852 cm À1 , respectively, and the peak between 595 and 630 cm À1 was ascribed to Fe-O vibrations.
Surface modication of Fe 3 O 4 with silica
OA-stabilized Fe 3 O 4 particles have the disadvantage that they are hydrophobic. To transfer such particles in water, in which all biological experiments are performed, it is necessary to modify their surface with a hydrophilic compound, such as SiO 2 . Hence, the starting Fe 3 O 4 nanoparticles were coated with a silica shell by a water-in-oil (w/o) reverse microemulsion method. The reaction is based on the ammonia-catalyzed hydrolysis of TMOS and the condensation of hydrolyzed silica species. The thickness of the silica layer on the particles, which is determinative for internalization in the cells, depends on the concentrations of the starting nanoparticles, silane precursor (TMOS), catalyst (ammonia), and surfactant (Igepal CO-520). 43 The silica thickness was thus controlled by changing the TMOS/Fe 3 O 4 ratio in the synthesis, which regulates the degree of hydrolysis and condensation, as well as inuencing the particle growth.
In the rst set of experiments, the optimal iron oxide concentration was determined, that led to formation of coreshell particles with properties satisfying all the requirements imposed on the resulting product. These include formation of homogeneous and robust silica shells around the particles without production of any additional neat silica. The Fe 3 O 4 content in the reaction feed was changed at a constant amount of hexane, NH 4 OH, Igepal CO-520, and TMOS.
When investigating the effect of the TMOS/Fe 3 O 4 ratio on the particle size and size distribution, the optimal ratio for formation of uniform silica shells on Fe 3 O 4 particles No. II was found to be 40 mL/30 mg (No. II/2 in Table 1 ; Fig. 2b) . At the ratio ¼ 40 mL/10 mg, neat silica particles were also produced (No. II/1 in Table 1 ; Fig. 2a ), while at 40 mL of TMOS/80 mg Fe 3 O 4 , inhomogeneous silica shells were formed on the particles (No. II/3 in Table 1 ; Fig. 2c ).
In the second set of experiments, the volume of TMOS in the reaction was varied to control the silica shell thickness on the particles No. I-III, while the other reactants (Fe 3 O 4 , hexane, NH 4 OH, and Igepal CO-520) were kept constant. TEM/EDX measurements proved the presence of silica (Fig. 3a) . The silica shell thickness increased from 3 to 5, from 5 to 13, and from 2. To minimize the toxicity of the silica-coated particles and to render them invisible to the reticuloendothelial system, i.e., to prevent their uptake by different cell types (macrophages and NSCs) and to increase the blood circulation time, the Fe 3 O 4 &-SiO 2 -NH 2 nanoparticles were modied with PEG, which is wellknown for hydrophilicity and nonionogenicity, 25 by reaction with its succinimidyl ester. The modication was documented by DLS and ATR FTIR spectroscopy. The Fe 3 O 4 &SiO 2 -PEG nanoparticles demonstrated good colloidal stability (D h ¼ 43 nm, PD ¼ 0.20), although the total negative surface charge was relatively low (À5 mV). ATR FTIR spectroscopy of the Fe 3 -O 4 &SiO 2 -PEG nanoparticles revealed new intensive peaks at 2925 and 2850 cm À1 , which were attributed to the asymmetric and symmetric stretching CH 2 vibrations (Fig. 3b) . (Fig. 4) . Flow cytometry and TEM conrmed these results and clearly showed that mNSCs did not internalize a signicant amount of Fe 3 O 4 &SiO 2 -PEG nanoparticles (Fig. 5 and 6 ). The uptake of 
Labelling efficiency and uptake of
27
TEM images clearly demonstrated that Fe 3 O 4 &SiO 2 particles were located both in the cytoplasm and membrane-bound vesicles aer uptake into mNSCs ( Fig. 6c and d) . The unique and desirable specic features of superparamagnetic nanoparticles may potentially induce cytotoxic effects and should be evaluated for each novel particle type, addressing biocompatibility and biosafety concerns associated with their usage.
38
Fe 3 O 4 &SiO 2 nanoparticles were found in endosomes of mNSCs (Fig. 6) , assuming the transfer of particles to lysosomes and the release of free iron ions into the cell cytoplasm aer lysosomal degradation. 47, 48 In the cytosol, nanoparticle-derived Fe ions are stored in ferritin, catalyze ROS generation and/or are used for Fedependent cellular processes.
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In this study, the response of mNSCs to treatment with Fe 3 O 4 &SiO 2 and Fe 3 O 4 &SiO 2 -PEG nanoparticles was evaluated by determination of cytotoxicity. This included cell viability and survival/mortality tests and investigation of oxidative stress, i.e., production of ROS, and study of changes in intracellular GSH levels and mitochondrial membrane potential. Fe 3 O 4 &SiO 2 -PEG nanoparticles, which were not actually taken up by the cells, had no cytotoxic effect (Fig. 7) . Even the highest concentration (200 mg L À1 ) of Fe 3 O 4 &SiO 2 -PEG nanoparticles did not signi-cantly affect either the survival or viability of mNSCs. For Fe 3 O 4 &SiO 2 particles, only their lowest concentrations had no inuence on the survival and viability of mNSCs. When the lowest possible concentration to achieve efficient cell labelling (20 mg L À1 ) was used, Fe 3 O 4 &SiO 2 particles decreased cell viability by more than 50% compared to the control, while cell mortality increased by less than 20% (Fig. 7) . It is interesting to note that the survival of mNSCs treated with 200 mg of Fe 3 O 4 &SiO 2 per L was ca. 50% compared to the control (Fig. 7) , while the same concentration of Fe 3 O 4 &SiO 2 labelled ca. 50% of live cells (Fig. 5) . This means that the number of labelled mNSCs was almost the same for 20 and 200 mg of Fe 3 O 4 &SiO 2 per L, indicating that the optimal particle dose for stem cell labelling was 20 rather than 200 mg L À1 . This was also supported by ICP-MS determination of the total Fe content in treated compared to control mNSCs (Fig. 5) . A ten-fold increase in (Fig. 8) . These results clearly showed that disturbances in cell functions leading to ROS production may occur either upon internalization of the nanoparticles or even upon contact with them.
The response of mNSCs to treatment with Fe 3 O 4 &SiO 2 and Fe 3 O 4 &SiO 2 -PEG nanoparticles was further evaluated by using the major endogenous antioxidant scavenger, GSH, as a biomarker. 50 An alteration in the GSH level is an elegant direct measure for the adaptive cellular response to oxidative damage. 51 Signicant depletion of GSH in mNSCs was observed for the highest dose of Fe 3 O 4 &SiO 2 , whereas all doses of Fe 3 O 4 &SiO 2 -PEG particles caused the opposite effect, i.e., a signicant increase in the GSH level aer 4 h (Fig. 8 ). These observations revealed that mNSCs activated antioxidative defense mechanisms when exposed to Fe 3 O 4 &SiO 2 and Fe 3 O 4 &SiO 2 -PEG nanoparticles. Depletion in GSH levels is considered an indirect measure for persistent oxidative stress caused by efficient degradation of the ROS, while increased GSH indicates triggering of a preventive cellular mechanism at an early stage of redox stress.
Measurements of changes in the mitochondrial membrane potential (MMP) provided additional evidence of oxidative stress response in mNSCs by Fe 3 O 4 &SiO 2 and Fe 3 O 4 &SiO 2 -PEG nanoparticles (Fig. 8) . Redox stress may perturb mitochondrial function in several ways, including dissipation or an increase in MMP. Changes in MMP were measured using the voltagedependent dye DiOC 6 in non-quenching mode at a nanomolar concentration. In addition, treatment of mNSCs was performed before staining. Using this experimental setup, a decrease in dye uorescence compared to control cells implies depolarized (less negative) mitochondria, which took a lower amount of dye. In contrast, higher uorescence in treated compared to control cells refers to hyperpolarized (more negative) mitochondria. Treatment of mNSCs with Fe 3 O 4 &SiO 2 for 4 h induced a dosedependent decrease in MMP compared to control cells (Fig. 8) , thus leading to the mitochondrial depolarization. Only the lowest dose of Fe 3 O 4 &SiO 2 did not induce signicant mitochondrial depolarization. Similar behavior has already been described for cells exposed to magnetite nanoparticles. 52 It is well-known that dissipation of MMP can be associated with ROS production and may be a prerequisite step for cell death by apoptosis or necrosis. 53 As expected, Fe 3 O 4 &SiO 2 -PEG nanoparticles, which were not internalized in the cells, did not signicantly change MMP. In contrast, treatment of mNSCs with hydrogen peroxide as the positive control (Fig. 6 ) caused mitochondrial membrane hyperpolarization in mNSCs, as described previously. 38 Again, similarly to the uncoated, Dmannose-, and poly(L-lysine)-coated maghemite nanoparticles, 38 our results showed that iron oxides may perturb cellular functions. Here, it was clearly demonstrated that surface coating has an important role in the design of nanoparticles enabling different modalities of biocompatibility and applicability in medicine. Fig. 7 Effect of different concentrations of Fe 3 O 4 &SiO 2 nanoparticles on mortality, survival, and viability of mNSCs relative to control after 24 h exposure. Control cells were cultivated in particle-free exposure media. Cell viability was measured by the MTT assay. Cell survival/ mortality was determined by flow cytometry. All data, calculated as percentages of the values in control cells, were expressed as the mean of three independent experiments conducted in five replicates. Error bars represent standard deviations. * -statistically significant difference (P < 0.05) versus control. Negative control cells were cultivated in nanoparticle-free exposure media, and positive controls were treated with 100 mM hydrogen peroxide. The data, expressed as the mean of three independent experiments conducted in five replicates, were calculated as percentages relative to negative controls. Error bars represent standard deviations. * -statistically significant difference (P < 0.05) compared to negative controls. . The relaxation times of particledoped phantom loads are given in Table 2 . As expected for a low iron oxide dosage, 55 there was no signicant impact of the nanoparticles on the T 1 relaxation time regardless of tested particle concentration, while a pronounced effect on the T 2 relaxation time and an even stronger effect on the T * 2 relaxation time were observed (Table 2 ). It should be noted, however, that T * 2 values are not a measure of tissue relaxation only, but of the local eld homogeneity as well, which in turn depends on the quality of shimming and can vary in the same sample from one scan session to another. 55 The worse the shimming, the shorter the T * 2 time. Thus, the T * 2 values (Table 2) are not to be taken as absolute reference values; rather, their purpose is to provide the basis for estimating the minimal particle concentration for sufficient contrast and reliable MRI detection in in vivo/ex vivo conditions. A T 2 =T * 2 value around one half of the typical T 2 =T * 2 of the surrounding tissue in a given application should be sufficient to produce negative contrast in T 2 -and T The effect of increasing Fe 3 O 4 &SiO 2 -PEG particle concentration in 20 vol% glycerol on the negative contrast is illustrated in Fig. 9 . Similar behavior was observed for Fe 3 O 4 &SiO 2 nanoparticles ( Table 2 ). The effect of shimming on the T * 2 relaxation time is visible in the rightmost column representing T * 2 maps, where the particle-doped phantom did not display steady values across the whole cross-section of the tube, unlike in the T 1 and T 2 maps. This effect was augmented for higher particle concentrations, as the decreased relaxation time resulted in reduced signal strength, thus making good shimming much harder to realize. ) were clearly visible in MRI images, as seen from the comparison between the T 2 -and T * 2 -weighted images of adult mouse brain ex vivo with injected particles (Fig. 10) . As expected, the contrast was much more pronounced in the T * 2 -weighted images. The contrast created by iron oxide particles in the surrounding tissue results from the fact that the iron oxide core disturbs the local magnetic eld creating magnetic inhomogeneity, to which acquisition schemes based on gradient echo sequences (for T * 2 -weighting) are much more susceptible. 55 
Conclusions
Fe 3 O 4 nanoparticles with uniform size and well-dened spherical shape were synthetized by thermal decomposition of Fe(III) oleate. Monodispersity of the nanoparticles ensures their uniform physical and chemical properties. By simple variation of the reaction parameters, such as the temperature and concentration of the stabilizer, the particle size was tuned from 6 to 20 nm. To facilitate particle dispersibility in aqueous media, Fe 3 O 4 was coated by silica via reverse microemulsion technique. Some Fe 3 O 4 &SiO 2 particles were also functionalized with aminosilica to allow facile conjugation of PEG-NHS through amide bond formation. Fe 3 O 4 &SiO 2 nanoparticles had a core-shell structure with a homogeneous silica layer on the surface. The thickness of the silica shell was controlled by selection of the reaction parameters, such as the TMOS/Fe 3 O 4 ratio and volume of TMOS added. Fe 3 O 4 &SiO 2 -PEG nanoparticles exhibited good colloidal stability in aqueous media, as conrmed by DLS and z-potential measurements.
The uptake of Fe 3 O 4 &SiO 2 -PEG nanoparticles by mNSCs was inferior to that of Fe 3 O 4 &SiO 2 , in agreement with reports that PEG can protect the particles from the immune cell system. A biocompatibility evaluation showed that Fe 3 O 4 &SiO 2 -PEG and Fe 3 O 4 &SiO 2 nanoparticles did not induce cytotoxic effects, although slight disturbances in cell function leading to ROS production, mitochondrial depolarization, and activation of antioxidative defense mechanisms may occur either upon internalization or even contact with the nanoparticles. Both types of nanoparticles at concentrations of 40 mg L À1 provided sufficient contrast for MRI, indicating their possible applications in cell labeling or as circulating contrast particles.
